AbbVie Inc (ABBV)

Payables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cost of revenue (ttm) US$ in thousands 36,852,000 35,318,000 34,557,000 36,331,000 35,682,000 35,832,000 34,109,000 32,414,000 32,444,000 32,808,000 33,431,000 32,382,000 27,416,000 24,738,000 16,662,000 9,843,000 7,439,000 7,455,000 7,370,000 7,485,000
Payables US$ in thousands 3,688,000 2,934,000 2,882,000 2,276,000 1,452,000
Payables turnover 9.99 12.16 11.26 12.05 5.12

December 31, 2023 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $36,852,000K ÷ $3,688,000K
= 9.99

Based on the available data, Abbvie Inc's payables turnover ratio for Q4 2023 is 5.54. This indicates that in the most recent quarter, Abbvie Inc was able to turn over its accounts payable approximately 5.54 times during the period.

Unfortunately, we do not have data for the previous quarters of 2023 to conduct a trend analysis or make a year-over-year comparison. However, in Q4 2022, the payables turnover ratio was slightly higher at 5.94, suggesting that the company was managing its accounts payable more efficiently in the corresponding quarter of the previous year.

Overall, a high payables turnover ratio like 5.54 indicates that Abbvie Inc is efficiently managing its accounts payable by paying off its suppliers relatively quickly. However, further analysis and comparison with industry averages or company historical data would provide a more comprehensive assessment of the company's payables management efficiency.


Peer comparison

Dec 31, 2023


See also:

AbbVie Inc Payables Turnover (Quarterly Data)